Tudor Investment Corp’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-20,611
Closed -$1.65M 3737
2025
Q2
$1.65M Buy
20,611
+8,074
+64% +$675K ﹤0.01% 1803
2025
Q1
$1.08M Sell
12,537
-4,299
-26% -$353K ﹤0.01% 1764
2024
Q4
$1.31M Buy
+16,836
New +$1.31M 0.01% 1539
2019
Q4
Sell
-52,504
Closed -$1.82M 1327
2019
Q3
$1.82M Buy
52,504
+1,318
+3% +$43.4K 0.06% 328
2019
Q2
$1.62M Buy
51,186
+3,672
+8% +$109K 0.05% 397
2019
Q1
$1.42M Buy
47,514
+14,545
+44% +$417K 0.06% 359
2018
Q4
$1.02M Buy
32,969
+5,327
+19% +$194K 0.02% 387
2018
Q3
$1.05M Buy
+27,642
New +$1.05M 0.03% 449
2018
Q2
Sell
-21,813
Closed -$736K 1183
2018
Q1
$736K Buy
21,813
+7,047
+48% +$270K 0.02% 437
2017
Q4
$656K Buy
14,766
+9,052
+158% +$412K 0.02% 497
2017
Q3
$286K Buy
+5,714
New +$292K 0.01% 842
2017
Q2
Sell
-6,700
Closed -$372K 1291
2017
Q1
$372K Buy
6,700
+600
+10% +$33.1K 0.01% 862
2016
Q4
$318K Sell
6,100
-1,300
-18% -$62.7K 0.01% 988
2016
Q3
$357K Buy
7,400
+300
+4% +$15.2K 0.01% 922
2016
Q2
$393K Sell
7,100
-7,862
-53% -$433K 0.01% 1004
2016
Q1
$799K Sell
14,962
-693
-4% -$34.1K 0.02% 650
2015
Q4
$806K Buy
15,655
+182
+1% +$9.04K 0.02% 568
2015
Q3
$699K Sell
15,473
-6,974
-31% -$329K 0.02% 564
2015
Q2
$1.04M Buy
22,447
+2,007
+10% +$87.8K 0.03% 397
2015
Q1
$877K Buy
20,440
+11,364
+125% +$433K 0.03% 437
2014
Q4
$315K Sell
9,076
-2,842
-24% -$94.3K 0.01% 1019
2014
Q3
$386K Buy
+11,918
New +$399K 0.01% 838
2014
Q1
Sell
-8,766
Closed -$314K 1364
2013
Q4
$314K Sell
8,766
-11,134
-56% -$370K 0.02% 860
2013
Q3
$599K Buy
+19,900
New +$651K 0.02% 269

Other funds holding PBH

Tudor Investment Corp's PBH Position: Q3 2025 in Review

Tudor Investment Corp sold out of Prestige Consumer Healthcare (PBH) in Q3 2025, closing a stake of 20,611 shares — an estimated $1.65M sold.

Tudor Investment Corp first reported a position in PBH in Q3 2013 and held it in 24 quarters. The position peaked at $1.82M in Q3 2019. 356 funds tracked by Wall St. Rank hold PBH as of Q3 2025.

  • Tudor Investment Corp reported no remaining Prestige Consumer Healthcare position as of Q3 2025 after selling out during the quarter.
  • Tudor Investment Corp sold 20,611 Prestige Consumer Healthcare shares in Q3 2025, an estimated $1.65M.
  • Tudor Investment Corp first reported a position in Prestige Consumer Healthcare in Q3 2013 and held it in 24 quarters.
  • Tudor Investment Corp's Prestige Consumer Healthcare position peaked at $1.82M in Q3 2019.
  • 356 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q3 2025.

Based on Tudor Investment Corp's 13F filing for Q3 2025, filed 14 Nov 2025.